Comments to FDA: Maximal Usage Trials for Topical Active Ingredients Being Considered for Inclusion in an OTC Monograph

Share page:
Docket Number:
FDA-2018-D-1456
Download Document
Issues:

Related Posts

We use cookies on this site to enhance your user experience

By clicking the Accept button, you agree to us doing so.